Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer

NCT02876640 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

27

Enrollment

NIH

Sponsor class

Stopped Inadequate Accrual Rate

Conditions

Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage IA Breast Cancer AJCC v8
Anatomic Stage IB Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage IIA Breast Cancer AJCC v8
Anatomic Stage IIB Breast Cancer AJCC v8
Breast Ductal Carcinoma In Situ
Early Stage Breast Carcinoma
Invasive Breast Carcinoma

Interventions

PROCEDURE: Biospecimen Collection
DRUG: Retinoid 9cUAB30
PROCEDURE: Therapeutic Conventional Surgery

Sponsor

National Cancer Institute (NCI)